Panoramica. Sia la vitamina D che la vitamina C contribuiscono alla salute della barriera intestinale supportando la funzione delle giunzioni strette e promuovendone la riparazione. La vitamina D, attraverso il suo recettore (VDR), regola le proteine che formano le giunzioni strette, che mantengono l’integrità della barriera e modulano il sistema immunitario. La vitamina C può anche promuovere la riparazione della barriera, potenzialmente regolando le vie di segnalazione di Notch e influenzando la composizione del microbioma intestinale, che può ulteriormente supportare la barrier
Ruolo della vitamina D
Giunzioni strette:
La forma attiva della vitamina D, 1,25(OH)2D3, regola l’espressione di proteine come le claudine e la ZO all’interno del complesso delle giunzioni strette, che sono cruciali per il mantenimento e la riparazione della barriera intestinale.
Modulazione immunitaria:
La vitamina D si lega ai recettori VDR nelle cellule immunitarie e modula le risposte immunitarie, contribuendo a proteggere da condizioni che possono compromettere la barriera, come le malattie infiammatorie intestinali.
Integrità della barriera:
Legandosi ai recettori VDR e influenzando le cellule immunitarie e le cellule epiteliali, la segnalazione della vitamina D contribuisce a mantenere una barriera intestinale sana e stabile.
Ruolo della vitamina C
Riparazione della barriera:
L’integrazione di vitamina C ha dimostrato effetti benefici sulla barriera intestinale, contribuendo a riparare i danni.
Segnalazione Notch:
In combinazione con la vitamina D, la vitamina C può regolare la via di segnalazione Notch per proteggere la barriera mucosa intestinale, inclusa l’espressione della claudina-2.
Microbioma intestinale:
L’integrazione di vitamina C può aiutare a bilanciare il microbiota intestinale in individui sani con livelli di vitamina C non ottimali, il che può indirettamente giovare alla barriera riducendo la presenza di batteri produttori di LPS potenzialmente dannosi.
Effetti combinati
Protezione sinergica:
La ricerca indica che la combinazione di vitamina C e vitamina D può offrire maggiori effetti protettivi sulla barriera intestinale rispetto all’assunzione di una delle due vitamine da sola, probabilmente attraverso la loro influenza combinata sulla via di segnalazione Notch.
Potenziale terapeutico:
Entrambe le vitamine sono oggetto di studio per il loro potenziale nella gestione delle patologie intestinali, migliorando l’integrità della barriera e modulando la risposta immunitaria nell’intestino.
Researches
1 – Gut-interplay: key to mitigating immunosenescence and promoting healthy ageing. 2025
Abstract
Background Immunosenescence is the loss and change of immunological organs, as well as innate and adaptive immune dysfunction with ageing, which can lead to increased sensitivity to infections, age-related diseases, and cancer. Emerging evidence highlights the role of gut-vitamin D axis in the regulation of immune ageing, influencing chronic inflammation and systemic health. This review aims to explore the interplay between the gut microbiota and vitamin D in mitigating immunosenescence and preventing against chronic inflammation and age-related diseases.
Main text
Gut microbiota dysbiosis and vitamin D insufficiency accelerate immunosenescence and risk of chronic diseases. Literature data reveal that vitamin D modulates gut microbiota diversity and composition, enhances immune resilience, and reduce systemic inflammation. Conversely, gut microbiota influences vitamin D metabolism to promote the synthesis of active vitamin D metabolites with implications for immune health.
Conclusions
These findings underscore the potential of targeting gut-vitamin D axis to modulate immune responses, delay the immune ageing, and mitigate age-related diseases. Further research is needed to integrate vitamin D supplementation and microbiome modulation into strategies aimed at promoting healthy ageing.
Keywords Gut microbiota, Vitamin D, Immune ageing, Immunosenescence, Healthy ageing
Gut-vitamin D interplay: key to mitigating immunosenescence and promoting healthy ageing. 2025. Hammad Ullah. https://doi.org/10.1186/s12979-025-00514-y
Hammad Ullah hammadrph@gmail.com 1 School of Pharmacy, University of Management and Technology, Lahore 54000, Pakistan
2 – Perspectives About Ascorbic Acid to Treat Inflammatory Bowel Diseases. Ian Richard Lucena Andriolo et al. 2024.
It is known that reactive oxygen species cause abnormal im- mune responses in the gut during inflammatory bowel dis- eases (IBD). Therefore, oxidative stress has been theorized as an agent of IBD development and antioxidant compounds such as vitamin C (L-ascorbic acid) have been studied as a new tool to treat IBD. Therefore, the potential of vitamin C to treat IBD was reviewed here as a critical discussion about this field and guide future research. Indeed, some preclinical studies have shown the beneficial effects of vitamin C in models of ulcerative colitis in mice and clinical and experimental findings have shown that deficiency in this vitamin is associated with the de- velopment of IBD and its worsening. The main mechanisms that may be involved in the activity of ascorbic acid in IBD in- clude its well-established role as an antioxidant, but also others diversified actions. However, some experimental studies em- ployed high doses of vitamin C and most of them did not per- form dose-response curves and neither determined the mini- mum effective dose nor the ED50. Allometric extrapolations were also not made. Also, clinical studies on the subject are still in their infancy. Therefore, it is suggested that the research agenda in this matter covers experimental studies that assess the effective, safe, and translational doses, as well as the ap- propriate administration route and its action mechanism. After that, robust clinical trials to increase knowledge about the role of ascorbic acid deficiency in IBD patients and the effects of their supplementation in these patients can be encouraged.
Perspectives and conclusion
The pathogenesis of IBD is closely related to oxidative stress due to an intense inflammatory insult and the use of vitamin C in IBD, as well as the role of its deficiency, is currently being investigated. Therefore, this perspective reviewed the pharmacological poten- tial of this vitamin to treat and prevent these diseases. In this ap- proach, Vitamin C may help the integrity of the intestinal barrier under the inflammatory stimulus, and enhance intestinal mucosal barrier function, while reducing oxidative stress.
However, a point that is worthy of attention in non-clinical stud- ies presented here is the dose used, which must be adequate for extrapolation in humans. Studies suggest that a daily intake of vi- tamin C from 100 to 400 mg promotes 100 % of the bioavailability and reaches a maximum serum content of 70–80 µmol/L [33, 34]. In addition, when the intake of vitamin C exceeds 500 mg/day, a further increase in plasma concentration is inhibited and when doses greater than 1,000 mg of ascorbic acid are administered in a single dose the bioavailability can decrease by 30 % [34]. This oc- curs because when 500–1,000 mg of vitamin C are administered orally, the intestinal transporter quickly achieves its maximal satu- ration, while the vitamin is progressively excreted by urine [34, 35].
Another important point, which has not yet been studied, is the impact of the pH of the ascorbic acid solution used in the experi- mental studies. Since the pH of an ascorbic acid solution is very low it is expected that its administration can reduce the pH at the in- jection site, intestine, and colon if an enema was used. So, further studies need to address this bias and evaluate the use of buffered ascorbic acid solutions. Perspectives About Ascorbic Acid to Treat Inflammatory Bowel Diseases. Ian Richard Lucena Andriolo et al. 2024. DOI 10.1055/a-2263-1388. ISSN 2194-9379